geraniin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
| Studies (geraniin) | Trials (geraniin) | Recent Studies (post-2010) (geraniin) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
|---|---|---|---|---|---|
| 94 | 1 | 66 | 6,010 | 10 | 772 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, H; Imayoshi, Y; Okabe, S; Suganuma, M; Taniguchi, S; Yoshida, T | 1 |
1 other study(ies) available for geraniin and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
New TNF-alpha releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki.
Topics: 3T3 Cells; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Chromatography, High Pressure Liquid; Glucosides; Hydrolyzable Tannins; Mice; Mice, Inbred BALB C; Plant Extracts; Plant Leaves; Plants, Medicinal; Skin Neoplasms; Tannins; Tumor Necrosis Factor-alpha | 2001 |